BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 5164628)

  • 1. [Evaluation of the antihypertensive action of methyldopa alone or in combination with hydrochlorothiazide].
    Mattar E; Cruz HM; Cruz J
    Rev Paul Med; 1971 Jul; 78(1):19-30. PubMed ID: 5164628
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparison of chlorthalidone-reserpine and hydrochlorothiazide-methyldopa as step 2 therapy for hypertension.
    Channick BJ; Kessler WB; Marks AD; Adlin EV
    Clin Ther; 1981; 4(3):175-83. PubMed ID: 7307035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the efficacy and safety of enalapril plus hydrochlorothiazide plus methyldopa vs standard triple therapy in the treatment of moderate to severe hypertension: results from a multicentre study.
    Leonetti G; Cuspidi C; Sampieri L; Ambrosioni E; Malini PL; Pessina A; Semplicini A; Cinotti G; Morabito S; Rappelli A
    J Hum Hypertens; 1990 Feb; 4(1):5-11. PubMed ID: 2189027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of guanethidine and methyldopa in essential hypertension: a controlled study.
    Glazer N
    Curr Ther Res Clin Exp; 1975 Mar; 17(3):249-56. PubMed ID: 805019
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy of an antihypertensive agent. Comparison of methyldopa and hydrochlorothiazide in combination and singly.
    McMahon FG
    JAMA; 1975 Jan; 231(2):155-8. PubMed ID: 1088916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Results of a national therapeutic trial in 10,000 hypertensive patients conducted by 2000 general practitioners (author's transl)].
    Jouve A; Goldet L; Mathieu M
    Sem Hop; 1978 Dec 8-15; 54(43-44):1363-8. PubMed ID: 219491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydrochlorothiazide plus methyldopa in the treatment of isolated systolic hypertension in the elderly.
    Boyles PW
    Clin Ther; 1984; 6(6):793-9. PubMed ID: 6509462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin converting enzyme inhibitors and quality of life: the European trial.
    Hill JF; Bulpitt CJ; Fletcher AE
    J Hypertens Suppl; 1985 Nov; 3(2):S91-4. PubMed ID: 3003305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiclinic evaluation of the antihypertensive effect of a methyldopa, hydrochlorothiazine, and amiloride combination.
    Moncloa F; Hwang IK; Muccilli AC
    Clin Ther; 1980; 3(3):168-75. PubMed ID: 7006811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methyldopa-hydrochlorothiazide therapy in hypertensive geriatric patients.
    Corman LA; Skversky NJ
    J Am Geriatr Soc; 1973 Jan; 21(1):36-9. PubMed ID: 4682564
    [No Abstract]   [Full Text] [Related]  

  • 11. A clinical trial of alpha-methyldopa (Aldomet) and hydrochlorthiazide (Dichlotride) alone and in combination in hypertension.
    Vaidya PM; Munshi CP; Sawkar LA; Parikh HM; Gulati OD
    Indian J Physiol Pharmacol; 1971 Jan; 15(1):35-41. PubMed ID: 4941549
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of a single daily low dose of methyldopa and K+ sparing diuretic on blood pressure in the elderly.
    Fidel J; Glikberg F
    Br J Clin Pract; 1988 Dec; 42(12):491-4. PubMed ID: 3256343
    [No Abstract]   [Full Text] [Related]  

  • 13. [Antihypertensive action and tolerance of alphamethyldopa and hydrochlorothiazide in fixed association versus single alphamethyldopa administration].
    Capuano V; De Martino M; Desiderio G; Riccio MD; De Vita S; Mondillo G
    G Clin Med; 1984; 65(7-8):367-74. PubMed ID: 6500213
    [No Abstract]   [Full Text] [Related]  

  • 14. [Antihypertensive effectiveness and tolerability of a combination of methyldopa and hydrochlorothiazide with and without potassium supplementation].
    De Giorgio LA; Innocenti F; Bartolomei GC
    G Clin Med; 1979 Sep; 60(9):729-47. PubMed ID: 262645
    [No Abstract]   [Full Text] [Related]  

  • 15. [Use of alpha-methyldopa and alpha-methyldopa combined with hydrochlorothiazide in hypertensive patients in ambulatory treatment: comparative study].
    Saldanha RV; Veras RO; de Paula e Silva P; de Serro-Azul LG
    Rev Paul Med; 1972 Apr; 79(3):61-6. PubMed ID: 4671321
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term antihypertensive, metabolic and cellular effects of enalapril.
    Malini PL; Strocchi E; Ambrosioni E; Magnani B
    J Hypertens Suppl; 1984 Dec; 2(2):S101-5. PubMed ID: 6100870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A combination of methyldopa, hydrochlorothiazide and amiloride in the treatment of essential hypertension].
    Bolzano K; Krempler F; Sandhofer F
    Acta Med Austriaca; 1984; 11(2):49-53. PubMed ID: 6377793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of single-dose methyldopa and diuretic on BP and left ventricular mass.
    Weinstein M; Hilewitz H; Rogel S
    Arch Intern Med; 1984 Aug; 144(8):1629-32. PubMed ID: 6235790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The combination of hydrochlorothiazide, amiloride and alpha-methyldopa in the treatment of arterial hypertension. Clinical evaluation of a multicentric study].
    Masacci E; Montemartini C; Bobba P; Croce L; Ricciardi S; Mussari A; Bernardi P; Dalla Torre M; Di Benedetto A; Santucci F; Lombardo M; Galassi A
    Minerva Cardioangiol; 1979 Dec; 27(12):801-6. PubMed ID: 550094
    [No Abstract]   [Full Text] [Related]  

  • 20. Effectiveness of twice-daily dosage of methyldopa in essential hypertension.
    Hollifield JW; Slaton PE
    J Tenn Med Assoc; 1978 May; 71(5):337-40. PubMed ID: 661299
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.